Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Reed

Showing results (791-800 of 873) with videos related to

Pageof 88
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2019
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated MalariaBenjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, et al.
The Lancet. Respiratory Medicine|December 11, 2020
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trialTracey A Day, Adam Penn-Nicholson, Angelique Kany Kany Luabeya, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2014
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responsesDiego A Vargas-Inchaustegui, Iskra Tuero, Venkatramanan Mohanram, et al.
Annals of the New York Academy of Sciences|August 23, 2018
Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacyWeidong Zhang, Adebayo J Molehin, Juan U Rojo, et al.
Journal of Virology|May 26, 2018
Control of Heterologous Simian Immunodeficiency Virus SIV<sub>smE660</sub> Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in MacaquesShakti Singh, Eric G Ramírez-Salazar, Rami Doueiri, et al.
Cell Reports|December 28, 2017
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal ModelsKevin O Saunders, Laurent K Verkoczy, Chuancang Jiang, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Nature Communications|June 9, 2017
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challengeTodd Bradley, Justin Pollara, Sampa Santra, et al.
Cell Reports|May 14, 2020
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV ChallengeBarbara K Felber, Zhongyan Lu, Xintao Hu, et al.
Pageof 88

Showing results (791-800 of 873) with videos related to

Sort By:
Pageof 88
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2019
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated MalariaBenjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, et al.
The Lancet. Respiratory Medicine|December 11, 2020
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trialTracey A Day, Adam Penn-Nicholson, Angelique Kany Kany Luabeya, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2014
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responsesDiego A Vargas-Inchaustegui, Iskra Tuero, Venkatramanan Mohanram, et al.
Annals of the New York Academy of Sciences|August 23, 2018
Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacyWeidong Zhang, Adebayo J Molehin, Juan U Rojo, et al.
Journal of Virology|May 26, 2018
Control of Heterologous Simian Immunodeficiency Virus SIV<sub>smE660</sub> Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in MacaquesShakti Singh, Eric G Ramírez-Salazar, Rami Doueiri, et al.
Cell Reports|December 28, 2017
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal ModelsKevin O Saunders, Laurent K Verkoczy, Chuancang Jiang, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Nature Communications|June 9, 2017
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challengeTodd Bradley, Justin Pollara, Sampa Santra, et al.
Cell Reports|May 14, 2020
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV ChallengeBarbara K Felber, Zhongyan Lu, Xintao Hu, et al.
Pageof 88